Lapam Capital logo

Lapam Capital

Asia, Beijing, China, Beijing

Description

Lapam Capital is a healthcare-focused venture capital firm.

Investor Profile

Lapam Capital has backed more than 4 startups, with 4 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Biotechnology, Therapeutics, Medical.
  • Led 2 rounds in the past year.

Stage Focus

  • Series A (75%)
  • Series B (25%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Medical
  • Alternative Medicine
  • Genetics
  • Manufacturing
  • Pharmaceutical
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lapam Capital frequently co-invest with?

GL Ventures LLC
Asia, Beijing, China, Beijing
Co-Investments: 1
Longzhu Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 2
XtalPi
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
Yael Capital Management Limited
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Lapam Capital?

LTZ Therapeutics

San Francisco, California, United States

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

BiotechnologyHealth CareMedical
Series AApr 24, 2025
Amount Raised: $40,000,000
Enchannel

Huangpu, Guangdong, China

Enchannel Medical is a global innovation platform that provides a one-stop atrial fibrillation treatment solutions.

BiotechnologyMedicalTherapeutics
Series BApr 23, 2025
Amount Raised: $82,338,411
Lingtai Biotechnology

Shanghai, Shanghai, China

Lingtai Biotechnology is a pharmaceutical and biotechnology based company that develops targeted protein degradation drugs.

BiotechnologyManufacturingPharmaceutical
Series ANov 18, 2024
Amount Raised: $13,819,026
ReviR Therapeutics

Brisbane, California, United States

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Alternative MedicineBiotechnologyGeneticsTherapeutics
Series AJul 26, 2024
Amount Raised: $30,000,000